Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
Tel: |
821-50328103-801 18930552037 |
Email: |
3bsc@sina.com |
Products Intro: |
Product Name:NSC 693868;1H-Pyrazolo[3,4-b]quinoxalin-3-aMine CAS:40254-90-8 Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
|
| 3-AMINO-1H-PYRAZOLO[3,4-B]QUINOXALINE Basic information |
Product Name: | 3-AMINO-1H-PYRAZOLO[3,4-B]QUINOXALINE | Synonyms: | 1H-PYRAZOLO[3,4-B]QUINOXALIN-3-AMINE;3-AMINO-1H-PYRAZOLO[3,4-B]QUINOXALINE;NSC 693868;1H-Pyrazolo[3,4-b]quinoxalin-3-amine(9CI);3-Aminopyrazolo[3,4-b]quinoxaline;1H-Pyrazolo[3,4-b]quinoxalin-3-ylamine;Cdk1/5 Inhibitor - CAS 40254-90-8 - Calbiochem;Brimonidine Impurity 8 | CAS: | 40254-90-8 | MF: | C9H7N5 | MW: | 185.19 | EINECS: | | Product Categories: | Protein Kinase;PIPERIDINE | Mol File: | 40254-90-8.mol | |
| 3-AMINO-1H-PYRAZOLO[3,4-B]QUINOXALINE Chemical Properties |
Melting point | 292-293℃ (ethanol ) | Boiling point | 522.8±45.0 °C(Predicted) | density | 1.570±0.06 g/cm3(Predicted) | storage temp. | Store at +4°C | solubility | Soluble to 100 mM in DMSO | form | Red solid | pka | 7.40±0.50(Predicted) |
Hazard Codes | T | Risk Statements | 25 | Safety Statements | 45 | RIDADR | UN 2811 6.1 / PGIII |
| 3-AMINO-1H-PYRAZOLO[3,4-B]QUINOXALINE Usage And Synthesis |
Description | Cyclin-dependent kinases (Cdks) are key regulators of cell cycle progression and are therefore promising targets for cancer therapy. Cdk1/5 Inhibitor is a pyrazolo [3,4-b] quioxaline that inhibits Cdk1/cyclin B and Cdk5/p25 (IC50s = 600 and 400 nM, respectively). It less potently inhibits GSK3β (IC50 = 1 μM) and does not block Cdc25 activity. This compound is used to help define the roles of Cdk1 and Cdk5 in various signaling pathways. | Uses | Cyclin-dependent kinases (CDKs) are protein kinases and involved with the regulation of the cell cycle. NSC 693868 is an inhibitor of Cdk1/cyclin B and Cdk5/p25.?Small molecules that target these protein kinases are valuable tools for investigating cellular signaling pathways and are potential therapeutic agents. | Definition | ChEBI: 2H-pyrazolo[4,3-b]quinoxalin-3-amine is a quinoxaline derivative. | Biological Activity | Inhibitor of cyclin-dependent kinases (cdks) and glycogen synthase kinase-3 (GSK-3). IC 50 values are 0.6, 0.4 and 1 μ M for cdk1/cyclin B, cdk5/p25 and GSK-3 respectively. |
| 3-AMINO-1H-PYRAZOLO[3,4-B]QUINOXALINE Preparation Products And Raw materials |
|